Kamada Ltd. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Kamada Ltd. (KMDA) holds an ST Score of 68.7 out of 100 (B+), with its strongest factor being Sentiment (A+) and its weakest Valuation (D-). Analysts rate KMDA Buy across 6 ratings with a $15.00 average price target (+0.7% vs the current $8.85).
- Strongest
- SentimentA+
- Weakest
- ValuationD-
All factor grades
- SentimentA+
- ProfitabilityA
- Financial StrengthA
- MomentumA
- ForecastB+
- GrowthC+
- ValuationD-
- Piotroski6/9
Contact
KMDA stock: frequently asked questions
What is KMDA's ST Score?
Kamada Ltd. (KMDA) has an ST Score of 68.7 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KMDA a buy, sell, or hold?
Wall Street's consensus rating on KMDA is Buy based on 6 analyst ratings. Our own ST Score grades it B+ (68.7/100). This is data, not investment advice — always do your own research.
What is KMDA's valuation grade?
Kamada Ltd. (KMDA) earns a valuation grade of D-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KMDA's growth grade?
Kamada Ltd. (KMDA) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KMDA's profitability grade?
Kamada Ltd. (KMDA) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KMDA's financial strength grade?
Kamada Ltd. (KMDA) earns a financial strength grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KMDA?
The average analyst price target for Kamada Ltd. (KMDA) is $15.00 from 6 analysts, which is +0.7% versus the recent price of $8.85.
What is KMDA's Piotroski score?
Kamada Ltd. (KMDA) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.